"That we observed this response using multiple aggressive ovarian cancer cell lines suggests that inhibiting this pathway has potential to enhance clinical outcomes for ovarian cancer patients." ...

"That we observed this response using multiple aggressive ovarian cancer cell lines suggests that inhibiting this pathway has potential to enhance clinical outcomes for ovarian cancer patients." ...

"That we observed this response using multiple aggressive ovarian cancer cell lines suggests that inhibiting this pathway has potential to enhance clinical outcomes for ovarian cancer patients." ...

Studying drug-induced metabolic changes with high-throughput systems shed light on drug modes of action, providing an ...

Deeper knowledge of the biology of ovarian cancer has led to the identification of multiple molecular targets, such as growth factor receptors, signal transduction pathways, cell cycle regulators ...

The following is a summary of "Role of MUC16 in tumor biology and tumor immunology in ovarian cancer," published in the ...

BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

Optimizing telehealth during public health emergencies to minimize in-person appointments puts less burden on patients and ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...